GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade) [Seeking Alpha]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Seeking Alpha
Summary Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, making it a risky investment. Q2 earnings showed minimal growth and a shrinking subscription base, with further challenges expected in Q3 due to store closures and program sunsets. Despite a reasonable valuation, GoodRx's ongoing struggles and lack of growth prospects make it advisable to sell and invest elsewhere. Maskot With the stock market continuing to tread highs amid a potential economic slide, I continue to emphasize careful stock selection as the best way to beat the markets from here on out. And in particular, economic weakness is likely to have This article was written by Gary Alexander 29.15K Follower s Follow With combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to sev
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Gen Z's expensive drug habit: More want brand-name meds that are 79% more expensive [Yahoo! Finance]Yahoo! Finance
- Gen Z's expensive drug habit: More want brand-name meds that are 79% more expensive [Fortune]Fortune
- What Is The Medicare Donut Hole Coverage Gap? [Forbes]Forbes
- Healthy Returns: What to know about Trump's NIH funding cuts [CNBC]CNBC
- LOKKER Appoints Geoffrey Golliher as Chief Technology Officer to Advance Data Privacy Innovation for Enterprises, Cyber Insurers and Law Firms [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 11/7/24 - Beat
GDRX
Sec Filings
- 2/13/25 - Form SCHEDULE
- 2/11/25 - Form 4
- 2/5/25 - Form 3
- GDRX's page on the SEC website